• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,913.50 -582.86
( -0.75%)
Global Indices
Nasdaq
49,530.46 -142.69
(-0.29%)
Dow Jones
7,252.74 22.73
(0.31%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,375.34 -3.48
(-0.03%)
Forex
USD-INR
94.96 0.17
(0.17%)
EUR-INR
111.11 0.25
(0.23%)
GBP-INR
128.48 0.55
(0.43%)
JPY-INR
0.60 0.01
(1.28%)

EQUITY - MARKET SCREENER

Nutraplus India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524764
INE230G01020
-1.6764374
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
7.16
EPS(TTM)
Face Value()
Div & Yield %
0
5
0
 

Wendt India consolidated net profit declines 60.51% in the March 2026 quarter
Apr 24,2026
Net profit of Wendt India declined 60.51% to Rs 5.09 crore in the quarter ended March 2026 as against Rs 12.89 crore during the previous quarter ended March 2025. Sales declined 12.17% to Rs 65.82 crore in the quarter ended March 2026 as against Rs 74.94 crore during the previous quarter ended March 2025.

For the full year,net profit declined 63.15% to Rs 14.55 crore in the year ended March 2026 as against Rs 39.48 crore during the previous year ended March 2025. Sales rose 1.21% to Rs 233.94 crore in the year ended March 2026 as against Rs 231.14 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales65.8274.94 -12 233.94231.14 1
OPM %16.3524.49 -13.7022.75 -
PBDT11.9320.45 -42 37.5461.30 -39
PBT7.8417.15 -54 22.8251.23 -55
NP5.0912.89 -61 14.5539.48 -63